My thoughts are the Teva deal is likely mostly baked in with the last order and the next future order and the sales from that. If there is news on the feed front that could raise it to a new 52 week high depending on how far advance the news is. If it is allowance for US testing maybe another 3 to 5 cents if it is past that and small scale use then it would likely bring us into the 20 to 30 cent range. There does seem to be larger purchases of this stock by a few people than alot of small retailers.>